Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AbbVie Inc. Director's Dealing 2018

Dec 28, 2018

29755_dirs_2018-12-28_96a5c6b6-1ace-4369-92b5-867c6ba2ab14.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2018-12-21

Reporting Person: Schumacher Laura J (Vice Chairman)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-12-21 Common stock, $0.01 par value G 1495 Disposed 159441 Direct
2018-12-24 Common stock, $0.01 par value G 119 Disposed 159322 Direct